Home - Products - Angiogenesis - VEGFR - BIBF 1202

BIBF 1202

CAS No. 894783-71-2

BIBF 1202( —— )

Catalog No. M29632 CAS No. 894783-71-2

BIBF 1202 is a VEGFR2 kinase inhibitor (IC50 = 62 nM).

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	791	Get Quote
10MG	1186	Get Quote
25MG	2131	Get Quote
50MG	3198	Get Quote
100MG	Get Quote	Get Quote
200MG	Get Quote	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

BIBF 1202
Note

Research use only, not for human use.
Brief Description

BIBF 1202 is a VEGFR2 kinase inhibitor (IC50 = 62 nM).
Description

BIBF 1202 is a VEGFR2 kinase inhibitor (IC50 = 62 nM).(In Vitro):BIBF 1202 is produced in the main metabolic pathway of BIBF 1120 by the cleavage of methyl esters. Then, the free carboxyl group of BIBF 1202 is glucuronidated to 1-O-acyl glucuronide .
In Vitro

The major metabolic pathway for BIBF 1120 is methyl ester cleavage to BIBF 1202. Subsequently, the free carboxyl group of BIBF 1202 is glucuronidated to 1-O-acylglucuronide.
In Vivo

——
Synonyms

——
Pathway

Angiogenesis
Target

VEGFR
Recptor

VEGFR
Research Area

——
Indication

——

Chemical Information

CAS Number

894783-71-2
Formula Weight

525.609
Molecular Formula

C30H31N5O4
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : ≥ 45 mg/mL (85.62 mM)
SMILES

CN(C(=O)CN1CCN(C)CC1)c1ccc(N\C(=C2/C(=O)Nc3cc(ccc23)C(O)=O)c2ccccc2)cc1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Sulfatinib (b)

Sulfatinib (HMPL-012) is a potent, multi-targeted tyrosine kinase inhibitor of VEGFR-1/2/3, FGFR1, CSF1R with IC50 of 2/24/1 nM, 15 nM, 4 nM, respectively.
Anlotinib Dihydrochl...

Anlotinib also known as AL3818 is a receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic and anti-angiogenic activities.
AKB-6899

AKB-6899 is an inhibitor of prolyl hydroxylase domain 3 (PHD3) and increases the soluble form of the VEGF receptor (sVEGFR-1) production from GM-CSF-treated macrophages.

Sign In Join Free